A Habr-Gama
Overview
Explore the profile of A Habr-Gama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
115
Citations
681
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cerdan-Santacruz C, Vailati B, Juliao G, Habr-Gama A, Perez R
Tech Coloproctol
. 2022 Aug;
27(1):1-9.
PMID: 35986804
Organ preservation strategies, especially watch and wait, after neoadjuvant treatment in locally advanced rectal cancer, have become topics that generate significant interest, for both patients and clinicians. The obvious advantage...
2.
Arezzo A, Lo Secco G, Passera R, Esposito L, Guerrieri M, Ortenzi M, et al.
Tech Coloproctol
. 2019 Aug;
23(9):831-842.
PMID: 31388861
Background: An organ-preserving strategy may be a valid alternative in the treatment of selected patients with rectal cancer after neoadjuvant radiotherapy. Preoperative assessment of the risk for tumor recurrence is...
3.
Perez R, Habr-Gama A
Colorectal Dis
. 2018 Jun;
20 Suppl 1:12-15.
PMID: 29878677
The surgical management of rectal cancer has evolved from a disease without any possibility of cure in the early 1700s where surgical management consisted of the palliative drainage of disease...
4.
Koyama F, Lopes Ramos C, Ledesma F, Alves V, Fernandes J, Vailati B, et al.
Br J Surg
. 2018 Jan;
105(2):e192-e203.
PMID: 29341150
Background: Neoadjuvant chemoradiotherapy (CRT) is one of the preferred initial treatment strategies for locally advanced rectal cancer. Responses are variable, and most patients still require surgery. The aim of this...
5.
Perez R, Habr-Gama A, Juliao G, Vailati B
Tech Coloproctol
. 2017 Sep;
22(2):141-142.
PMID: 28891016
No abstract available.
6.
Juliao G, Habr-Gama A, Vailati B, Perez R
Tech Coloproctol
. 2017 Jun;
21(7):573-575.
PMID: 28631136
No abstract available.
7.
Juliao G, Ortega C, Vailati B, Habr-Gama A, Fernandez L, Gama-Rodrigues J, et al.
Colorectal Dis
. 2017 Apr;
19(6):O196-O203.
PMID: 28436197
Aim: Full-thickness local excision after neoadjuvant chemoradiotherapy (CRT) for patients with rectal cancer and incomplete clinical response has been a treatment strategy for organ preservation. Follow-up of these patients is...
8.
Beets G, Figueiredo N, Habr-Gama A, van de Velde C
Eur J Surg Oncol
. 2015 Oct;
41(12):1562-4.
PMID: 26493223
No abstract available.
9.
Perez R, Habr-Gama A, Juliao G, Lynn P, Sabbagh C, Proscurshim I, et al.
Tech Coloproctol
. 2014 Feb;
18(8):699-708.
PMID: 24509716
Background: Molecular imaging using positron emission tomography/computerized tomography (PET/CT) may add relevant incremental diagnostic information to standard structural cross-sectional imaging. Such information may allow identification of patients with rectal cancer...
10.
Perez R, Habr-Gama A, Juliao G, Proscurshim I, Ono C, Lynn P, et al.
Colorectal Dis
. 2013 Feb;
15(6):674-82.
PMID: 23374979
Aim: Inguinal nodes may be a possible route for lymphatic spread in patients with distal rectal cancer. The outcome was examined for patients with distal rectal cancer undergoing neoadjuvant chemoradiation...